載入...

Overview of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Patients with Type 2 Diabetes

BACKGROUND: It is estimated that 29.1 million people or 9.3% of the US population have diabetes, which contributes to considerable medical and financial burden. Type 2 diabetes mellitus is characterized by insulin resistance and insulin secretion impairment leading to hyperglycemia. The presence of...

全面介紹

Na minha lista:
書目詳細資料
發表在:Am Health Drug Benefits
Main Authors: Tran, Kelvin Lingjet, Park, Young In, Pandya, Shalin, Muliyil, Navin John, Jensen, Brandon David, Huynh, Kovin, Nguyen, Quang T.
格式: Artigo
語言:Inglês
出版: Engage Healthcare Communications, LLC 2017
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5536194/
https://ncbi.nlm.nih.gov/pubmed/28794822
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!